Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 4
273
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Litoarbolide A: an undescribed sesquiterpenoid from the Red Sea soft coral Litophyton arboreum with an in vitro anti-malarial activity evaluation

ORCID Icon, , ORCID Icon, , , , ORCID Icon, ORCID Icon & show all
Pages 542-550 | Received 16 Dec 2021, Accepted 25 Apr 2022, Published online: 02 May 2022
 

Abstract

Soft corals distributed across the Red Sea coasts are a rich source of diverse and bioactive natural products. Chemical probing of the Red Sea soft coral Litophyton arboreum led to isolation and structural characterization of an undescribed sesquiterpenoid, litoarbolide A (1), along with 14 previously reported metabolites (2-15). The chemical structures of the isolates were assigned based on NMR as well as high resolution electrospray ionization mass spectrometry (HR-ESI-MS) data. Litoarbolide A is supposed to be the biosynthetic precursor to other sesquiterpenoids, which formed via further post-translational modifications. Furthermore, these metabolites were evaluated for anti-malarial activity, where only the acyclic sesquiterpenoid of a sec-germacrane nucleus (7) showed an activity against chloroquine-sensitive (D6) and chloroquine-resistant (W2) strains of Plasmodium falciparum with IC50 at 3.7 and 2.2 mg/mL, respectively. Moreover, the isolated metabolites were all non-toxic to the Vero cell line. These findings support the consideration of L. arboreum in further natural anti-malarial studies.

Graphical Abstract

Acknowledgements

We are grateful to the Egyptian Government represented by the Ministry of Higher Education (MoHE) for the financial support. The authors thank Dr. Avula for acquiring the mass spectral data.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

This research was funded by the Egyptian government represented by the Ministry of Higher Education (MoHE).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.